Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash Flow Statement
Cash Flow Statement
Bicycle Therapeutics PLC
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||
Net Income |
(24)
|
(21)
|
(22)
|
(26)
|
(31)
|
(33)
|
(31)
|
(35)
|
(37)
|
(38)
|
(51)
|
(56)
|
(62)
|
(66)
|
(67)
|
(78)
|
(87)
|
(101)
|
(113)
|
(124)
|
(140)
|
(162)
|
(181)
|
(168)
|
|
Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
5
|
6
|
6
|
7
|
7
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(7)
|
(9)
|
(1)
|
3
|
5
|
|
Stock-Based Compensation |
0
|
0
|
1
|
1
|
2
|
3
|
3
|
5
|
5
|
6
|
7
|
8
|
9
|
11
|
12
|
18
|
22
|
24
|
27
|
26
|
28
|
30
|
32
|
33
|
|
Other Non-Cash Items |
2
|
2
|
2
|
5
|
8
|
7
|
8
|
7
|
5
|
6
|
7
|
8
|
10
|
11
|
13
|
19
|
22
|
25
|
27
|
26
|
29
|
31
|
34
|
34
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Change in Working Capital |
7
|
(0)
|
(7)
|
(4)
|
(4)
|
(7)
|
(7)
|
25
|
24
|
25
|
25
|
(6)
|
(2)
|
33
|
38
|
30
|
25
|
7
|
1
|
(6)
|
66
|
82
|
77
|
38
|
|
Cash from Operating Activities |
(14)
N/A
|
(19)
-33%
|
(26)
-40%
|
(24)
+8%
|
(26)
-10%
|
(33)
-24%
|
(29)
+12%
|
(2)
+92%
|
(7)
-211%
|
(6)
+13%
|
(18)
-192%
|
(53)
-196%
|
(53)
0%
|
(21)
+60%
|
(15)
+30%
|
(27)
-86%
|
(39)
-41%
|
(66)
-71%
|
(86)
-30%
|
(106)
-23%
|
(49)
+54%
|
(44)
+10%
|
(61)
-39%
|
(85)
-40%
|
|
Investing Cash Flow | |||||||||||||||||||||||||
Capital Expenditures |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(6)
|
(16)
|
(19)
|
(19)
|
(16)
|
(7)
|
(4)
|
(3)
|
(1)
|
|
Cash from Investing Activities |
(2)
N/A
|
(2)
+6%
|
(1)
+28%
|
(1)
-13%
|
(1)
-5%
|
(2)
-11%
|
(2)
+1%
|
(1)
+6%
|
(1)
+11%
|
(1)
+14%
|
(1)
-7%
|
(2)
-25%
|
(1)
+9%
|
(1)
-5%
|
(2)
-41%
|
(6)
-204%
|
(16)
-156%
|
(19)
-18%
|
(19)
-2%
|
(16)
+14%
|
(7)
+58%
|
(4)
+36%
|
(3)
+32%
|
(1)
+71%
|
|
Financing Cash Flow | |||||||||||||||||||||||||
Net Issuance of Common Stock |
58
|
7
|
26
|
27
|
85
|
84
|
58
|
57
|
(1)
|
47
|
48
|
107
|
123
|
117
|
306
|
247
|
232
|
191
|
7
|
9
|
21
|
256
|
250
|
249
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
15
|
30
|
30
|
15
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
0
|
0
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
58
N/A
|
7
-89%
|
25
+285%
|
25
+0%
|
85
+232%
|
84
-1%
|
58
-30%
|
58
0%
|
(1)
N/A
|
61
N/A
|
63
+3%
|
137
+118%
|
152
+11%
|
132
-14%
|
321
+143%
|
247
-23%
|
232
-6%
|
191
-17%
|
7
-97%
|
9
+34%
|
21
+135%
|
256
+1 114%
|
250
-2%
|
249
0%
|
|
Change in Cash | |||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
2
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
0
|
(4)
|
(3)
|
(0)
|
0
|
4
|
3
|
0
|
(1)
|
(2)
|
(3)
|
(5)
|
(1)
|
(0)
|
2
|
4
|
1
|
0
|
|
Net Change in Cash |
44
N/A
|
(15)
N/A
|
(4)
+71%
|
(3)
+25%
|
55
N/A
|
48
-13%
|
29
-40%
|
50
+75%
|
(12)
N/A
|
54
N/A
|
44
-19%
|
86
+97%
|
102
+18%
|
110
+8%
|
303
+176%
|
211
-30%
|
174
-18%
|
102
-41%
|
(100)
N/A
|
(114)
-14%
|
(32)
+72%
|
211
N/A
|
188
-11%
|
164
-13%
|
|
Free Cash Flow | |||||||||||||||||||||||||
Free Cash Flow |
(16)
N/A
|
(20)
-29%
|
(27)
-35%
|
(25)
+7%
|
(28)
-9%
|
(34)
-23%
|
(30)
+12%
|
(4)
+88%
|
(8)
-123%
|
(7)
+13%
|
(19)
-163%
|
(54)
-185%
|
(54)
+0%
|
(22)
+59%
|
(17)
+25%
|
(34)
-100%
|
(54)
-62%
|
(85)
-56%
|
(105)
-24%
|
(122)
-17%
|
(55)
+55%
|
(48)
+13%
|
(64)
-32%
|
(86)
-35%
|